Status: Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
Participants needed: 595
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Parabilis Medicines, Inc.Updated: May 28, 2026Locations: 33
Eligibility criteria
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. [+16]
Known history of bone metastasis. Bone metastasis are allowed for patients with... [+6]